Protera Biosciences
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $9.4M
Investors
- 3
About Protera Biosciences
Based in France, Protera Biosciences, Inc.Protera Biosciences, Inc. was founded in Paris, France in 2015, and operates with a focus on creating advanced protein solutions for the food sector.Protera specializes in the development of innovative functional ingredients for the food industry, leveraging advanced protein engineering and artificial intelligence. Their core offerings include the madi™ platform, designed to tackle complex challenges related to protein functionality, discovery, and production efficiency. Through generative AI and computational biology, Protera aims to unlock novel protein applications via precision fermentation at an industrial scale.Protera's revenue model is structured around partnerships and collaborations with food industry stakeholders, encompassing both B2B transactions and direct-to-consumer offerings. Client interactions typically involve long-term contracts or agreements for unique protein ingredients developed through the madi™ platform. Companies may engage in subscription-based arrangements for ongoing access to Protera's products or services, ensuring a steady flow of revenue.Protera Biosciences, Inc. The company aims to expand its product offerings and enhance its capabilities within the food innovation sector. Specific future products are currently in development, with plans to enter new markets in Europe and North America by 2023, addressing the increasing demand for sustainable food solutions.
Who invested in Protera Biosciences
3 investors across 3 rounds
See all investors in Protera Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Protera Biosciences
Who invested in Protera Biosciences?
Protera Biosciences has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Protera Biosciences raised?
Protera Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Protera Biosciences last raise money?
Protera Biosciences's most recent round on record is a Series A, in Oct 2021.
What does Protera Biosciences do?
Based in France, Protera Biosciences, Inc.
Where is Protera Biosciences headquartered?
Protera Biosciences is headquartered in Paris, France.
Which VCs invest in companies like Protera Biosciences?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Protera Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Protera Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.